Biotech · Private company
Aerovate Therapeutics
Track this companyFree. Adds Aerovate Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- AV-101Phase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)PHASE3 · TERMINATED · started Nov 2, 2022ClinicalTrials.gov NCT05557942 · fetched Nov 12, 2026
- A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)PHASE2_PHASE3 · TERMINATED · started Dec 2, 2021ClinicalTrials.gov NCT05036135 · fetched Nov 12, 2026